Mark R. Green - Concepedia

Author

Mark R. Green

Also Known As

Green, Mark R., Lemke, Kristine, M R Green, MARK R. GREEN, Mark R Green, Mark R. Green, Turrisi, Andrew T, Vokes, Everett, Vokes, Everett E.

171

Publications

13.2K

Citations

H-Index

Concepts

All Affiliations

Medical University of South Carolina Duke Medical Center Duke University University of Chicago Duke University Hospital

About

Mark R. Green is an author at Medical University of South Carolina specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	46	4.2K
2	Health Sciences	12	14	1K
3	Cell Biology	2	2	38
4	Hepatology	1	1	56
5	Immunology	1	1	14

Mark R. Green

Publications

12.3K

Citations

H-Index

Page 1

	Year	Citations
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Kathy S. Albain, Ruth Swann, Valerie W. Rusch, The Lancet Surgical OncologySurgical ResectionRadiation TherapyMedicinePhase Iii	2009	1.5K
A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer Robert O. Dillman, Stephen L. Seagren, Kathleen J. Propert, New England Journal of Medicine	1990	1.2K
Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD George P. Canellos, James R. Anderson, Kathleen J. Propert, New England Journal of Medicine	1992	1.2K
Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups Gary M. Strauss, James E. Herndon, Michael A. Maddaus, Journal of Clinical Oncology	2008	975
Irinotecan Plus Gemcitabine Results in No Survival Advantage Compared With Gemcitabine Monotherapy in Patients With Locally Advanced or Metastatic Pancreatic Cancer Despite Increased Tumor Response Rate Caio M. Rocha Lima, Mark R. Green, Robert Rotche, Journal of Clinical Oncology	2004	580
Video-Assisted Thoracic Surgery Lobectomy: Report of CALGB 39802—A Prospective, Multi-Institution Feasibility Study James E. Herndon, Thomas A. D’Amico, Todd L. Demmy, Journal of Clinical Oncology	2007	573
Factors Predictive of Survival Among 337 Patients With Mesothelioma Treated Between 1984 and 1994 by the Cancer and Leukemia Group B James E. Herndon, Mark R. Green, A. Phillippe Chahinian, CHEST Journal Hematological MalignancyMedicineFactors PredictiveCancer ManagementPathology	1998	506
Chemotherapy with or without Radiation Therapy in Limited Small-Cell Carcinoma of the Lung Michael C. Perry, Walter L. Eaton, Kathleen J. Propert, New England Journal of Medicine Initial RadiotherapyRadiation MedicineRadiation TherapyMedicineToxic Effects	1987	489
Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Regionally Advanced Unresectable Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Everett E. Vokes, James E. Herndon, Michael J. Kelley, Journal of Clinical Oncology	2007	471
Single-Agent Versus Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The Cancer and Leukemia Group B (study 9730) Rogério Lilenbaum, James E. Herndon, Marcy A. List, Journal of Clinical Oncology	2004	451

Page 1